These findings collectively indicate that inhibiting NOX2 could mitigate ROS production, reduce myofibroblast activation, limit extracellular matrix component accumulation, and slow the progression of pulmonary fibrosis [43,47]. This evidence concerns the gene CYBB and pulmonary fibrosis.